SCHEMBL8739738

SCHEMBL8739738

C=NNC(=O)CCSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26469358 0.78 LMNA (0.69) —
SCHEMBL8738823 0.77 — —
SCHEMBL19503361 0.77 MAPT (0.42) —
SCHEMBL14262185 0.75 LMNA (0.48) —
SCHEMBL11496642 0.75 — —
SCHEMBL7904847 0.72 — —
SCHEMBL12418604 0.72 — —
SCHEMBL18222982 0.72 HDAC3 (0.48) —
SCHEMBL2774768 0.70 — —
SCHEMBL11489356 0.69 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9695240-B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds GENENTECH, INC. (US) 2017-07-04 — — US disclosed
US-20150051380-A1 ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS GENENTECH, INC. (US) 2015-02-19 — — US disclosed
US-8900589-B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds GENETECH, INC. (US) 2014-12-02 — — US disclosed
US-8389697-B2 Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds GENENTECH, INC. (US) 2013-03-05 — — US disclosed
US-20120130059-A1 ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS BERIA ITALO (IT) 2012-05-24 — — US disclosed
US-20100034837-A1 ANTHRACYCLINE DERIVATIVE CONJUGATES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS ANTITUMOR COMPOUNDS GENENTECH, INC. 2010-02-11 — — US disclosed
Send feedback